- Home
- CREV vs ENSC Comparison
CREV vs ENSC Comparison
Compare CREV & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREV
- ENSC
- Stock Information
- Founded
- CREV 2007
- ENSC 2003
- Country
- CREV Ireland
- ENSC United States
- Employees
- CREV N/A
- ENSC N/A
- Industry
- CREV
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- CREV
- ENSC Health Care
- Exchange
- CREV Nasdaq
- ENSC Nasdaq
- Market Cap
- CREV 6.0M
- ENSC 6.4M
- IPO Year
- CREV N/A
- ENSC N/A
- Fundamental
- Price
- CREV $4.16
- ENSC $2.10
- Analyst Decision
- CREV
- ENSC
- Analyst Count
- CREV 0
- ENSC 0
- Target Price
- CREV N/A
- ENSC N/A
- AVG Volume (30 Days)
- CREV 29.1K
- ENSC 54.6K
- Earning Date
- CREV 05-14-2025
- ENSC 11-11-2025
- Dividend Yield
- CREV N/A
- ENSC N/A
- EPS Growth
- CREV N/A
- ENSC N/A
- EPS
- CREV N/A
- ENSC N/A
- Revenue
- CREV $39,261,077.00
- ENSC $7,413,722.00
- Revenue This Year
- CREV $40.76
- ENSC N/A
- Revenue Next Year
- CREV $86.18
- ENSC $1,354.55
- P/E Ratio
- CREV N/A
- ENSC N/A
- Revenue Growth
- CREV 41.52
- ENSC 415.58
- 52 Week Low
- CREV $2.00
- ENSC $1.62
- 52 Week High
- CREV $12.75
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- CREV 48.99
- ENSC 48.61
- Support Level
- CREV $3.92
- ENSC $2.02
- Resistance Level
- CREV $4.30
- ENSC $2.19
- Average True Range (ATR)
- CREV 0.35
- ENSC 0.10
- MACD
- CREV -0.01
- ENSC 0.00
- Stochastic Oscillator
- CREV 33.46
- ENSC 41.45
About CREV Carbon Revolution Public Limited
Carbon Revolution PLC is an Australian-based technology company manufacturing carbon fiber wheels. It is an OEM supplier and a world-wide manufacturer of lightweight technology carbon fibre wheels to the automotive industry. The Company supplies wheels to OEMs across the globe for luxury and high-performance vehicles and SUVs, and is developing wheels for electric vehicles under contract for its OEM customers. The company generates maximum revenue Internationally.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.